SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-135385
Filing Date
2016-11-18
Accepted
2016-11-18 16:08:41
Documents
75
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v452803_10q.htm 10-Q 468843
2 EXHIBIT 31.1 v452803_ex31-1.htm EX-31.1 8844
3 EXHIBIT 31.2 v452803_ex31-2.htm EX-31.2 8764
4 EXHIBIT 32.1 v452803_ex32-1.htm EX-32.1 4417
5 EXHIBIT 32.2 v452803_ex32-2.htm EX-32.2 4766
12 GRAPHIC pg27img1.jpg GRAPHIC 83392
13 GRAPHIC pg27img2.jpg GRAPHIC 29069
14 GRAPHIC pg29img1.jpg GRAPHIC 58824
15 GRAPHIC pg29img2.jpg GRAPHIC 98305
  Complete submission text file 0001144204-16-135385.txt   5821091

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imnp-20160930.xml EX-101.INS 1129969
7 XBRL TAXONOMY EXTENSION SCHEMA imnp-20160930.xsd EX-101.SCH 57502
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20160930_cal.xml EX-101.CAL 48268
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20160930_def.xml EX-101.DEF 447976
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20160930_lab.xml EX-101.LAB 441856
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20160930_pre.xml EX-101.PRE 472816
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36602 | Film No.: 162007896
SIC: 2834 Pharmaceutical Preparations